Press Releases iBio, Inc.

Equities

IBIO

US4510337086

Market Closed - Nyse Other stock markets 04:10:00 2024-04-26 pm EDT			5-day change	1st Jan Change
1.76 ^USD	+2.33%		+2.33%	+28.47%

Apr. 01	IBio, Inc. announced that it has received $15.066157 million in funding from ADAR1 Capital Management, LLC, Lynx1 Capital Management LP, Ikarian Capital, LLC and other investors	CI
Mar. 28	Top Premarket Gainers	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

IBio and AstralBio Announce Transformative AI drug discovery Collaboration to Rapidly Develop Novel Antibodies for Obesity and Cardiometabolic Diseases	Mar. 27	AQ
IBio Announces $15.0 Million Private Placement	Mar. 26	AQ
IBio Announces Sale of Preclinical PD-1 Agonist Antibody Program to Otsuka	Feb. 26	AQ
IBio Announces Participation in 23rd Annual PepTalk Conference	Jan. 16	AQ
IBio Amends and Extends Maturity of Credit Agreement	Dec. 26	AQ
IBio, Inc. Announces Pricing of $4.5 Million Public Offering	Dec. 05	AQ
IBio Announces Reverse Stock Split	Nov. 27	AQ
IBio Further Expands Tech Stack with ShieldTx™; Enhances Immuno-Oncology Development Pipeline with Conditionally Activated MUC16xCD3 Bispecific	Nov. 01	AQ
IBio to Highlight Technology for Advancing Discovery of Bispecifics at Festival of Biologics	23-10-10	AQ
IBio Explains Recent Filing of Registration Statement	23-10-02	AQ
IBio Announces Filing of 2023 Annual Report on SEC Form 10-K	23-09-27	AQ
IBio Announces Amendment to Credit Agreement with Woodforest	23-09-21	AQ
IBio Reports Triple Milestone: In Vivo Proof-of-Concept for Three Programs, a Transformative Step in Advancing its Immuno-Oncology Pre-Clinical Pipeline Towards Clinical Development	23-08-14	AQ
IBio Appoints Dr. Martin Brenner as CEO, Felipe Duran as CFO to Oversee Company’s Next Stage of Growth	23-06-27	AQ
IBio : Emerging growth company ☐ - Form 8-K	23-06-20	PU
IBio Forges Research Collaboration with the National Institutes of Health	23-06-12	AQ
IBio Expands Tech Stack with EngageTx™; Adds TROP-2 Bispecific to Development Pipeline	23-06-06	AQ
IBio to Participate in the JMP Securities Life Sciences Conference	23-05-09	AQ
IBIO, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	23-04-24	AQ
IBio Discovers New Panel of CD3 T-Cell Binding Antibodies Using its Patented AI Epitope Steering Platform	23-04-04	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases iBio, Inc.

Equities

IBIO

US4510337086

Press Releases

Filters